Sentence examples for morbidity evaluation from inspiring English sources

Therefore, it was necessary to exclude the patients dying during sedation, analgesia, and paralysis from the morbidity evaluation.

Morbidity evaluation of all rats during the observation phase, as reflected by their daily neurological deficit scores, showed significant difference between all groups.

Child morbidity: The incidences of respiratory infection and diarrhea are assessed at one and three months postpartum, concurrent with maternal morbidity evaluations.

As the order of treatment will depend on the presence of and severity of co-morbidities, evaluation of co-morbid disorders is a key component of the ADHD assessment using appropriate clinical diagnostic approaches.

Morbidities evaluation for the current pregnancy included mother's arterial hypertension (yes/no), anemia (yes/no), miscarriage threat (yes/no), premature labor (yes/no), vaginal bleeding in the last trimester (yes/no), and urinary tract infection (yes/no).

Early primary care diagnosis, monitoring, and management of patients with anemia and cardiovascular morbidity and evaluation of iron, vitamin B12, folic acid, and nutritional status may be worthwhile.

Following documentation of the advantages of using ECMO to manage neonatal respiratory insufficiency in terms of both mortality and morbidity, the evaluation of pharmacotherapy during neonatal ECMO should become a second step toward a more evidence-based approach to these patients.

The ongoing BEAUTIFUL (morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction) study is assessing the effect of ivabradine on cardiovascular outcomes in patients with both CAD and left ventricular systolic dysfunction, and the results of this major clinical trial are expected in 2008 (Fox et al. 2006).

The prognostic relevance of heart rate in patients with coronary artery disease and reduced ejection fraction recently has been demonstrated in the placebo arm of the prospective BEAUTIFUL (morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction) study.

Primary outcome is a composite of perinatal death, and severe neonatal morbidity up to evaluation at 6 months after birth.

The range of morbidity widens with evaluation after age one, when assessment of cognitive skills, coordination, behavioural difficulties, and sensory loss can be more precise [ 16].